Cambridge Innovation Capital has released its annual results, celebrating a 46% increase in net asset value and its first IPO exit.

Cambridge Innovation Capital (CIC), the patient capital fund aligned with University of Cambridge, released its annual statement on Monday for the year ended March 31, 2020, celebrating a range of key successes.
The fund’s portfolio now consists of 30 companies and net assets have grown by 46% to more than £301m ($377m), equating to a fair value increase of $87m and, together with investments, a portfolio value of $365m – up from $243m for the previous period.
…

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?
Thierry Heles

Thierry Heles is editor-at-large of Global University Venturing and Global Corporate Venturing, and host of the Beyond the Breakthrough podcast.
Email LinkedIn